Catalyst Pharmaceutical Partners Aktie
17,97
EUR
-0,28
EUR
-1,53
%
21,57
USD
+0,65
USD
+3,11
%
Werbung
Catalyst Pharmaceutical Partners Aktie Analyse
21.09.18 | Catalyst Pharmaceutical Partners Overweight | Cantor Fitzgerald | |
30.09.14 | Catalyst Pharmaceutical Partners Buy | ROTH Capital Partners, LLC | |
14.11.12 | Catalyst Pharmaceutical Partners buy | ROTH Capital Partners, LLC | |
29.11.07 | Catalyst Pharmaceutical Partners market outperform | Rodman & Renshaw |
Werbung
Werbung